David Boulware

Has grant

University of Minnesota

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

Determining the performance and accuracy of SILVAMP TB LAM and cost-effectiveness of diagnostic testing for TB meningitis.

Open Date: 2022-06-21

Close Date: 2027-05-31

Grant: Close

11th International Conference on Cryptococcus and Cryptococcosis (ICCC)

Open Date: 2022-02-01

Close Date: 2023-01-31

Grant: Close

TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies

Open Date: 2021-08-01

Close Date: 2026-07-31

Grant: Close

High Dose Oral Rifampicin to Improve Survival from Adult TB Meningitis - (HARVEST) Trial

Open Date: 2019-05-31

Close Date: 2023-05-30

Grant: Close

Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics

Open Date: 2019-03-11

Close Date: 2024-02-29

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (17)

Nathan C. Bahr

University of Kansas Medical Center

UNITED STATES

View details

Tom Luedde

GERMANY

View details

Caleb P Skipper

University of Minnesota

UNITED STATES

View details

Matthew Pullen

University of Minnesota

UNITED STATES

View details

Joshua Rhein

University of Minnesota

UNITED STATES

View details

Michael Wilson

Professor

University of California, San Francisco

UNITED STATES

View details

Todd Lee

Associate Professor of Medicine

McGill University

CANADA

View details

Melanie R Nicol

University of Minnesota

UNITED STATES

View details

George R. Thompson

UNITED STATES

View details

Torsten Feldt

GERMANY

View details

Andrej Spec

Assistant Professor

Washington University in St. Louis

UNITED STATES

View details

Biyue Dai

University of Minnesota

UNITED STATES

View details

Carolyn T. Bramante

University of Minnesota

UNITED STATES

View details

Colin R. MacKenzie

GERMANY

View details

Leda Kobziar

Associate Professor and Director, Master of Natural Resources

University of Idaho

UNITED STATES

View details

Sarah M Lofgren

University of Minnesota

UNITED STATES

View details

Thomas Harrison

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Boulware

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (30)

Etiology and Outcomes of Meningitis among Adults in Three Ugandan Referral Hospitals, 2018-2023: A Prospective Cohort Study in a High-HIV Endemic Setting.

Cerebral Perfusion Pressures and Implications on Clinical Outcomes and Medical Management in Cryptococcal Meningitis

Spatiotemporal Association of Coronavirus Disease 2019 Cases and Deaths With Exposure to Wildfire Particulate Matter in 2020

Metformin and Time to Sustained Recovery in Adults With COVID-19

The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death

Experience of research nurses with oral encochleated amphotericin B for treatment of cryptococcal meningitis in a resource-limited setting

Experiences, challenges, gaps, and strategies for counselling persons presenting with advanced HIV-associated meningitis in Uganda

Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease

Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis

Molecular diagnostics improve the yield of diagnosis of community-acquired pneumonia and multidrug-resistant pathogens in hospitalised patients with HIV in a low-income setting

Baseline C-reactive Protein as a Risk Factor for Cryptococcal Meningitis and Death in HIV-associated Cryptococcal Antigenemia With CrAg Titer as an Effect Modifier

Global guideline for the diagnosis and management of cryptococcosis

A Comparison of Recruitment Methods for a Remote, Nationwide Clinical Trial for COVID-19 Treatment

A Comparison of Recruitment Methods for a Remote, Nationwide Clinical Trial for COVID-19 Treatment

Mid-Upper Arm Circumference Is a Strong Predictor of Mortality Among Ugandan Adults With HIV-Associated Cryptococcal Meningitis

When Someone Should Do Something About This

Infectious Diseases Physician Management of Cryptococcal Meningitis in North America - Is Single High-Dose Liposomal Amphotericin B Being Used?

Randomized trial of mechanotherapy for the treatment of stress urinary incontinence in women

Complex Decisions in HIV-Related Cryptococcosis: Addressing Second Episodes of Cryptococcal Meningitis

Complex Decisions in HIV-Related Cryptococcosis

Disseminated Cryptococcosis Is a Common Finding among Human Immunodeficiency Virus-Infected Patients with Suspected Sepsis and Is Associated with Higher Mortality Rates

Prevalence of <i>Histoplasma</i> Antigenuria among Outpatient Cohort with Advanced HIV in Kampala, Uganda

Ongoing Need for Clinical Trials and Contemporary End Points for Outpatient COVID-19

Differences in Reasons for Late Presentation to HIV Care in Uganda Among Men and Women

Differences in Reasons for Late Presentation to HIV Care in Uganda Among Men and Women

Adherence of health workers to guidelines for screening and management of cryptococcal meningitis in Uganda

Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence Model

Effect of Coronavirus Disease 2019 (COVID-19) Lockdowns on Identification of Advanced Human Immunodeficiency Virus Disease in Outpatient Clinics in Uganda

Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19 A Randomized Clinical Trial

Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19 A Randomized Clinical Trial

Collaborators (17)

Nathan C. Bahr

Tom Luedde

Caleb P Skipper

Matthew Pullen

Joshua Rhein

Michael Wilson

Todd Lee

Melanie R Nicol

George R. Thompson

Torsten Feldt

Andrej Spec

Biyue Dai

Carolyn T. Bramante

Colin R. MacKenzie

Leda Kobziar

Sarah M Lofgren

Thomas Harrison

Make your next move.